Mandate

Vinge advises BHG Group in connection with its acquisition of Hemmy

February 24, 2022 Employment and Benefits M&A

Vinge has advised BHG Group AB’s group company within household appliances and household products, Vitvaruexperten.com Nordic AB, in connection with its acquisition of approximately 51% of Hemmy AB with an option to acquire up to 100%.

Hemmy.se conducts online sales of consumer appliances, household appliances and home and garden products in Sweden. In 2021, Hemmy.se’s turnover was MSEK 103.

BHG Group is the largest online actor within consumer trading in the Nordic region and the largest online actor in Europe within Home Improvement, which includes both Do-It-Yourself and Home Furnishing. BHG Group’s online trading operations has approximately 2,000 employees and includes more than 100 online destinations and 70 showrooms. The head office is situated in Malmö with operations in most European countries. BHG Group is listed on Nasdaq Stockholm.

Vinge’s team consisted of Kristian Ford, Sofie Nordgren, Carl Trolle Olsson, Daniel Melander Björner, Lisa Bourghardt, Simona Mullai, Martin Svanberg and Johanne Örnfeldt Svensson.

 

Related

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025